<DOC>
	<DOC>NCT02213991</DOC>
	<brief_summary>The purpose of this study is to evaluate acute local toxicity of IORT at the dose of 20 Gy for the replacement of boost-external beam radiotherapy in Korean women who are candidates for breast-conserving treatment.</brief_summary>
	<brief_title>Intraoperative Radiotherapy for Korean Patients With Breast Cancer</brief_title>
	<detailed_description>Local toxicity checklist - Hematoma needing surgical evacuation - Seroma needing more than three aspirations - Skin breakdown or delayed wound healing - Any complication needing surgical intervention - Radiation Therapy Oncology Group (RTOG version 2.0) toxicity grade 3 or 4 for dermatitis, telangiectasia, pain in irradiated field, or other. - Any complication of RTOG toxicity grade more than 2</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Histologically confirmed and newly diagnosed nonmetastatic operable primary breast cancer Primary tumor &lt;5cm, measured by ultrasonography N03 (any N if resectable) and no evidence of distant metastasis (M) (isolated supraclavicular node involvement allowed) Age â‰¥18years women with good performance status (ECOG 01) No breast operation is allowed except diagnostic biopsy Women with ductal carcinoma in situ diagnosed by preoperative biopsy are allowed Pregnancy or unwillingness to use a reliable contraceptive method in women of childbearing potential. Patients who received prior chemotherapy or radiotherapy for breast cancer Patients who have history of cancer other than in situ uterine cervix cancer or nonmelanoma skin cancer The depth of tumor from skin measured by ultrasonography is less than 1cm. Contraindications to breast conservative surgery Multicentric breast cancer (tumors in more than one quadrant) Diffuse malignant appearing microcalcification Prior therapeutic radiation to the breast region Small breast, which is not possible to achieve clear margins in relation to a cosmetically acceptable result History of collagen vascular disease, such as active scleroderma and active lupus Postoperative exclusion Patients who require reexcision due to positive resection margin The depth of cavity from skin after lumpectomy is less than 0.5cm</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Breast Conservative Surgery</keyword>
	<keyword>Intraoperative Radiotherapy</keyword>
	<keyword>Local Toxicity</keyword>
	<keyword>Whole breast radiotherapy</keyword>
</DOC>